P
Principia BioPharma
Biopharmaceutical company focused on oncology and autoimmune disease
Latest news
Press, funding announcements and product moves mentioning Principia BioPharma.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- NPNew Leaf Venture Partners
Series B and later8 investors entered at this stage
- SOSR One
- SISofinnova Investments
Cormorant Asset Management- UCUniversity of California
- SFSan Francisco
- MCMission Bay Capital
- MVMorgenthaler Ventures
OrbiMed
Source: Dealroom Talent Intelligence.
Alumni founders
Former Principia BioPharma employees who went on to found companies, sorted by Dealroom signal score.
STSilverback TherapeuticsEst. 2016
Peter ThompsonUnited States
KSKezar Life SciencesEst. 2015
APAngel PharmaceuticalsEst. 2020
Richard Miller, MDChina
David GoldsteinUnited StatesGlobal footprint
team presence
across markets
Patents
71 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Principia BioPharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Principia BioPharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.